#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5105455	B	Agonist activity at human TLR2/TLR6 expressed in HEK-Blue hTLR2-TLR6 cells by SEAP reporter gene based Quanti-blue assay	Homo sapiens	11	ALA5104121	cell-based format	Scientific Literature
2.	ALA5105456	B	Agonist activity at TLR2/TLR6 in human PBMC cells assessed as increase in IL-6 production at 0.1 ug/ml incubated for 24 hrs	Homo sapiens	7	ALA5104121	cell-based format	Scientific Literature
3.	ALA5105457	B	Agonist activity at TLR2/TLR6 in human PBMC cells assessed as increase in IL-10 production at 0.1 ug/ml incubated for 24 hrs	Homo sapiens	7	ALA5104121	cell-based format	Scientific Literature
4.	ALA5105458	B	Agonist activity at TLR2/TLR6 in human PBMC cells assessed as increase in TNF-alpha production at 0.1 ug/ml incubated for 24 hrs	Homo sapiens	7	ALA5104121	cell-based format	Scientific Literature
5.	ALA5105463	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen B cells assessed as increase in CD40 expression incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	2	ALA5104121	tissue-based format	Scientific Literature
6.	ALA5105464	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen B cells assessed as increase in CD86 expression incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	2	ALA5104121	tissue-based format	Scientific Literature
7.	ALA5105465	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen dendritic cells assessed as increase in CD40 expression incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	2	ALA5104121	tissue-based format	Scientific Literature
8.	ALA5105466	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen dendritic cells assessed as increase in CD86 expression incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	2	ALA5104121	tissue-based format	Scientific Literature
9.	ALA5105467	F	Immuno-adjuvant activity in C57BL/6 mouse immunized with recombinant hepatitis B surface antigen assessed as increase in anti-HBs antibody at 10 ug, IM administered twice 2 weeks apart by ELISA analysis	Mus musculus	4	ALA5104121	organism-based format	Scientific Literature
10.	ALA5105468	F	Immuno-adjuvant activity in C57BL/6 mouse immunized with recombinant hepatitis B surface antigen assessed as increase in IgG2/IgG1 ratio at 10 ug, IM administered twice 2 weeks apart by ELISA analysis	Mus musculus	2	ALA5104121	organism-based format	Scientific Literature
11.	ALA5105469	F	Immuno-adjuvant activity in C57BL/6 mouse immunized with recombinant influenza A/California/04/2009 HA protein assessed as increase in anti-HAs antibody at 10 ug, IM administered twice 2 weeks apart by ELISA analysis	Mus musculus	5	ALA5104121	organism-based format	Scientific Literature
12.	ALA5105470	F	Protection against influenza A/California/04/2009 virus-challenged C57BL/6 mouse assessed as effect on body weight at 10 ug, IM administered twice 2 weeks apart along with recombinant influenza A/California/04/2009 HA protein immunization	Mus musculus	5	ALA5104121	organism-based format	Scientific Literature
13.	ALA5105471	F	Protection against influenza A/California/04/2009 virus-challenged C57BL/6 mouse assessed as effect on survival at 10 ug, IM administered twice 2 weeks apart along with recombinant influenza A/California/04/2009 HA protein immunization	Mus musculus	5	ALA5104121	organism-based format	Scientific Literature